Philip Tsai
Patrimonio netto: 945 239 $ in data 31/05/2026
Patrimonio netto: 945 239 $ in data 31/05/2026
Philip Tsai is Chief Technical Officer at Immunome, Inc. since 2024.
Dr. Tsai was Senior Vice President-Technical Development at Seagen, Inc. from 2021 to 2024.
Education includes graduate and doctorate degrees from California Institute of Technology and an undergraduate degree from the University of Illinois At Urbana–Champaign.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOME, INC. 0,04% | 19/12/2025 | 43.300 ( 0,04% ) | 945 239 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOME, INC. | Direttore Tecnico/Scientifico/R&S | 27/06/2024 |
| Società | Posizione | Fine |
|---|---|---|
| SEAGEN INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2024 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois At Urbana–Champaign
University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale